Skip to main content
GLAUKOS Corp logo

GLAUKOS Corp — Investor Relations & Filings

Ticker · GKOS ISIN · US3773221029 LEI · 5299004JA1LHE21M6T14 US Manufacturing
Open in API
Filings indexed 981 across all filing types
Latest filing 2026-06-03 Declaration of Voting R…
Country US United States of America
Listing US GKOS

About GLAUKOS Corp

https://www.glaukos.com

Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company that develops and commercializes novel therapies for chronic eye diseases. The company focuses on advancing the standard of care for conditions such as glaucoma, corneal disorders, and retinal diseases. A pioneer in the field of Micro-Invasive Glaucoma Surgery (MIGS), Glaukos is committed to innovation through significant reinvestment in research and development to create transformative treatments. In addition to its product pipeline, the company provides comprehensive clinical support and educational resources for physicians to help integrate its technologies into their practices and improve patient outcomes.

Recent filings

Filing Released Lang Actions
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 93% confidence The document is a Form 8-K current report where Item 5.07 “Submission of Matters to a Vote of Security Holders” provides the final voting results for proposals at the annual meeting. This matches the definition for Declaration of Voting Results & Voting Rights Announcements (Code: DVA).
2026-06-03 English
SD
Regulatory Filings Classification · 95% confidence The document is a U.S. SEC Form SD (Specialized Disclosure Report) for conflict minerals, filed under Rule 13p-1 for the 2025 reporting period. It does not contain financial statements or earnings data, nor is it an AGM, proxy, dividend notice, or similar. It is a compliance/regulatory submission under the Securities Exchange Act. As such, it falls under the fallback category for miscellaneous regulatory filings (Regulatory Filings).
2026-05-29 English
8-K - GLAUKOS Corp (0001192448) (Filer)
Regulatory Filings
2026-05-04 English
8-K - GLAUKOS Corp (0001192448) (Filer)
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. It includes references to a press release announcing financial results for the first quarter ended March 31, 2026, and a Quarterly Summary with supplemental business and financial information for the same period. The document itself does not contain detailed financial statements or substantive financial data but rather references exhibits containing the press release and quarterly summary. The length is 4332 characters, which is relatively short and consistent with an announcement rather than a full report. According to the rules, when a document is short and primarily announces or furnishes other reports or press releases, it should be classified as a Regulatory Filing (RNS) rather than an Interim/Quarterly Report (IR) or Earnings Release (ER). Therefore, the appropriate classification is Regulatory Filings (RNS).
2026-04-29 English
ARS - GLAUKOS Corp (0001192448) (Filer)
Annual Report
2026-04-16 English
DEF 14A - GLAUKOS Corp (0001192448) (Filer)
Proxy Solicitation & Information Statement
2026-04-16 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.